Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

422
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
422
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

2.6K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.6K
Management of Insomnia01:19

Management of Insomnia

450
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
450
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

341
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
341

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nocturnal Features and Daytime Characteristics in Narcolepsy: Reliability and Diagnostic Relevance for NT1 vs NT2.

Sleep·2026
Same author

Postmortem Evidence of CRH Neuron Reduction in Narcolepsy Without Cataplexy With Borderline Hypocretin-1 Levels.

Journal of sleep research·2026
Same author

Slow-Wave Sleep Fragmentation in Disorders of Arousal and Sleep-Related Hypermotor Epilepsy: A Multicenter Polysomnographic Study.

Neurology·2026
Same author

The association of vitamin D deficiency with depressive disorders in patients with eating disorders: a cross-sectional study.

Journal of eating disorders·2026
Same author

Diagnostic Value of Psychomotor Vigilance Task for Severe Sleep Inertia in Idiopathic Hypersomnia Versus Other Sleep Disorders Without Sleep Inertia.

Journal of sleep research·2026
Same author

Exposure to Global Burden of Disease dietary factors and risk of recurrent depressive symptoms: the prospective Whitehall II cohort study.

European journal of nutrition·2026

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K

Narcolepsy Severity Scale: a reliable tool assessing symptom severity and consequences.

Yves Dauvilliers1,2, Lucie Barateau1,2, Regis Lopez1,2

  • 1National Reference Network for Narcolepsy, Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, University of Montpellier, Montpellier, France.

Sleep
|January 30, 2020
PubMed
Summary

The Narcolepsy Severity Scale (NSS) is a valid tool for assessing narcolepsy type 1 (NT1) severity. It effectively tracks treatment response and establishes four clinically relevant severity ranges for patient care and research.

Keywords:
cataplexynarcolepsyscaleseveritysleepinesstreatment

More Related Videos

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.6K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.2K
Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments
08:36

Collecting Sleep, Circadian, Fatigue, and Performance Data in Complex Operational Environments

Published on: August 8, 2019

12.6K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.6K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Clinical Assessment Tools

Background:

  • Narcolepsy Type 1 (NT1) significantly impacts quality of life.
  • Objective measures are needed to quantify NT1 severity and treatment efficacy.
  • The Narcolepsy Severity Scale (NSS) is a 15-item questionnaire assessing core NT1 symptoms.

Purpose of the Study:

  • To establish clinically relevant scoring ranges for the NSS.
  • To confirm the performance and medication sensitivity of the NSS.
  • To evaluate the necessity of item weighting in the NSS.

Main Methods:

  • 143 untreated and 238 treated NT1 adults completed the NSS, ESS, BDI, and EQ5D.
  • NSS scores were analyzed for validity, reliability, and responsiveness to treatment.
  • Statistical comparisons were made between treated and untreated groups.

Main Results:

  • Significant differences in NSS scores and symptom counts were observed between untreated and treated NT1 patients (p < 0.0001).
  • Item weighting was not necessary for the NSS to detect group differences.
  • Four severity levels (mild, moderate, severe, very severe) were defined, correlating with treatment status and other clinical measures (ESS, BDI, EQ5D).

Conclusions:

  • The NSS is a valid, reliable, and treatment-responsive instrument for NT1.
  • Four clinically relevant severity score ranges for the NSS have been established.
  • The NSS possesses adequate clinimetric properties for expanded clinical and research applications.